TruTrace Technologies Inc Share Price Canadian Securities Exchange
Equities
CA8984471075
Advanced Medical Equipment & Technology
Sales 2021 | 0.16 0.22 13.56 | Sales 2022 | 0.12 0.16 9.88 | Capitalization | 3.82M 5.22M 319M |
---|---|---|---|---|---|
Net income 2021 | -1M -1.37M -83.44M | Net income 2022 | -2M -2.73M -167M | EV / Sales 2021 | 8,37,73,009 x |
Net cash position 2021 | 893K 1.22M 74.5M | Net Debt 2022 | 681K 931K 56.82M | EV / Sales 2022 | 3,79,73,468 x |
P/E ratio 2021 |
-6.71
x | P/E ratio 2022 |
-1.64
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 87.1% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 11/11/11 | |
Robert Lelovic
DFI | Director of Finance/CFO | - | 16/21/16 |
James LaValle
CTO | Chief Tech/Sci/R&D Officer | - | 21/19/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Cesare Fazari
BRD | Director/Board Member | - | 09/20/09 |
Robert Galarza
BRD | Director/Board Member | 45 | 17/18/17 |
Allan O'Dette
CHM | Chairman | - | 06/20/06 |
1st Jan change | Capi. | |
---|---|---|
-10.97% | 27.7B | |
+22.59% | 8.46B | |
+27.70% | 4.3B | |
-36.30% | 2.41B | |
-8.48% | 1.62B | |
-16.00% | 1.45B | |
-32.60% | 1.16B | |
+2.77% | 919M | |
-40.61% | 830M |